Studies on the use of needle-free injection device on proteins

被引:11
作者
Benedek, K
Walker, E
Doshier, LA
Stout, R
机构
[1] iGORi, Thousand Oaks, CA 91360 USA
[2] Bioject Inc, Portland, OR USA
关键词
needle-free injection; protein stability; protein HPLC; pressure injection; biopharmaceuticals; drug delivery;
D O I
10.1016/j.chroma.2005.03.098
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the following communication we report the evaluation of 18 proteins that were processed by a specific needle free injection device. The processed protein samples were analyzed by two HPLC techniques, reversed-phase liquid chromatography (RPLC) and size-exclusion chromatography (SEC). These techniques are two of the most widely used analytical techniques in the biopharmaceutical industry for the characterization, integrity assessment and stability study of peptide and protein products. The results indicate that needle free injection, using the specific device of this study, is not damaging to the studied proteins and does not generate aggregates. We found no evidence of the predicted possible effects of needle free injections, and concluded that needle free delivery is in general not different than any other delivery system and that its use should be evaluated on a case by case basis. It has to be noted that there are various needle free device designs and our work was performed using an Iject (R) from Bioject. Our conclusions therefore should be limited to the Iject (R) design we used in this study. In the reported experiments we used commercially available (economical) model proteins, which facilitate the use of the results for future comparison and reference. The work reported here can serve as a reference to illustrate the benign nature of our needle free injection device. It also highlights an interesting analogy between a set of phobias that were seen to have plagued the early stages of biochemistry and HPLC, on the one hand, and some attitudes that appear to hinder the widespread acceptance of needle free injection at present time, on the other. These phobias were identified and named by Professor Csaba Horvath, the father of HPLC, as barophobia, siderophobia and lithophobia. Today a wealth of evidence is available to indicate that those phobias are ungrounded and that the negative observations can be explained in most cases by adsorption and prevented by proper formulations and solvent conditions. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:397 / 407
页数:11
相关论文
共 32 条
[1]   Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe [J].
Agerso, H ;
Moller-Pedersen, J ;
Cappi, S ;
Thomann, P ;
Jesussek, B ;
Senderovitz, T .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (11) :1262-1268
[2]   REPORT OF LARGE-SCALE FIELD TRIAL OF JET INJECTION IN IMMUNIZATION FOR INFLUENZA [J].
ANDERSON, EA ;
LINDBERG, RB ;
HUNTER, DH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1958, 167 (05) :549-552
[3]   KINETICS OF UNFOLDING OF PROTEINS ON HYDROPHOBIC SURFACES IN REVERSED-PHASE LIQUID-CHROMATOGRAPHY [J].
BENEDEK, K ;
DONG, S ;
KARGER, BL .
JOURNAL OF CHROMATOGRAPHY, 1984, 317 (DEC) :227-243
[4]   Pressure denaturation of β-lactoglobulin -: Different stabilities of isoforms A and B, and an investigation of the Tanford transition [J].
Botelho, MM ;
Valente-Mesquita, VL ;
Oliveira, KMG ;
Polikarpov, I ;
Ferreira, ST .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (08) :2235-2241
[5]   MOBILE-PHASE AND TEMPERATURE EFFECTS IN THE REVERSED PHASE CHROMATOGRAPHIC-SEPARATION OF PROTEINS [J].
COHEN, KA ;
SCHELLENBERG, K ;
BENEDEK, K ;
KARGER, BL ;
GREGO, B ;
HEARN, MTW .
ANALYTICAL BIOCHEMISTRY, 1984, 140 (01) :223-235
[6]   CONFORMATIONAL EFFECTS IN THE REVERSED-PHASE LIQUID-CHROMATOGRAPHY OF RIBONUCLEASE-A [J].
COHEN, SA ;
BENEDEK, K ;
TAPUHI, Y ;
FORD, JC ;
KARGER, BL .
ANALYTICAL BIOCHEMISTRY, 1985, 144 (01) :275-284
[7]  
DAVIES JW, 1969, CAN J PUBLIC HLTH, P104
[8]  
Dörr HG, 2003, J PEDIATR ENDOCR MET, V16, P383
[9]  
ELISBERG BL, 1956, J IMMUNOL, P340
[10]   Hb Ernz [β123(H1)Thr→Asn] and Hb Renert [β133(H11)Val→Ala]:: Two new neutral variants revealed by reversed phase high performance liquid chromatography analysis [J].
Groff, P ;
Kalmes, G ;
Golinska, B ;
Miyazaki, A ;
Riou, J ;
Carte, N ;
Promé, D ;
Kister, J ;
Galactéros, F ;
Wajcman, H .
HEMOGLOBIN, 2000, 24 (04) :287-297